Establishment Labs (ESTA) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$245.8M

Revenue (quarter)

$67.5M

Revenue growth (year over year)

+31.66%

Gross profit (trailing twelve months)

$173.3M

Gross margin

70.49%

Net income (trailing twelve months)

−$38.9M

Net income (quarter)

−$11.7M

Net income growth (year over year)

+29.20%

Net margin

−15.82%

Return on equity

−175.30%

EPS (trailing twelve months)

−$1.27

Book value per share

$0.73

P/E (trailing twelve months)

—

Price to book

82.17

Debt to assets

93.86%

Payout ratio

—

Dividend yield

—

Company profile

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

• Is Establishment Labs (ESTA) profitable?

  No. Establishment Labs reported a net loss of $38.9M over the trailing twelve months.

• How much revenue does Establishment Labs (ESTA) make?

  Establishment Labs generated $245.8M in revenue over the trailing twelve months, up 31.66% year over year.

• How do I buy stock in Establishment Labs (ESTA)?

  ESTA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.